- Home
- ALGS vs BHM Comparison
ALGS vs BHM Comparison
Compare ALGS & BHM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ALGS | BHM |
|---|---|---|
| Founded | 2018 | 2022 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Real Estate Investment Trusts |
| Sector | Health Care | Real Estate |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 34.6M | 35.5M |
| IPO Year | 2020 | 2022 |
Fundamental Metrics
Financial Performance| Metric | ALGS | BHM |
|---|---|---|
| Price | $4.80 | $8.05 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 8 | 0 |
| Target Price | ★ $52.38 | N/A |
| AVG Volume (30 Days) | ★ 35.4K | 2.2K |
| Earning Date | 11-05-2026 | 01-01-0001 |
| Dividend Yield | N/A | ★ 6.25% |
| EPS Growth | ★ 88.30 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | $2,186,000.00 | ★ $68,734,000.00 |
| Revenue This Year | $1,562.10 | $1.31 |
| Revenue Next Year | N/A | $11.18 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 36.88 |
| 52 Week Low | $3.98 | $7.86 |
| 52 Week High | $13.69 | $13.30 |
Technical Indicators
Market Signals| Indicator | ALGS | BHM |
|---|---|---|
| Relative Strength Index (RSI) | 36.83 | 47.76 |
| Support Level | N/A | N/A |
| Resistance Level | $6.91 | $8.55 |
| Average True Range (ATR) | 0.35 | 0.31 |
| MACD | -0.04 | 0.01 |
| Stochastic Oscillator | 21.84 | 27.33 |
Price Performance
Historical ComparisonAbout ALGS Aligos Therapeutics Inc.
Aligos Therapeutics Inc is a clinical-stage biotechnology company focused on developing therapeutics for liver diseases and viral infections. Its pipeline includes drug candidates targeting chronic hepatitis B virus (HBV) infection, metabolic dysfunction-associated steatohepatitis (MASH), obesity, and coronavirus infections, with programs such as pefivfoscorvir sodium for HBV, ALG-055009 for MASH and obesity, and ALG-097558 for coronavirus infections.
About BHM Bluerock Homes Trust Inc.
Bluerock Homes Trust Inc owns and operates a portfolio of institutional residential properties including single-family homes, build-to-rent communities, and other residential communities located in attractive markets with a focus on the knowledge-economy and high-quality of life growth markets of the Sunbelt and Western United States. The company's principal objective is to generate attractive risk-adjusted returns on investments where it believes it can drive growth in funds from operations and net asset value by acquiring residential units, developing residential communities, and through value-add renovations. The company has two reportable segments, consisting of Residential Communities, which derives maximum revenue; and Scattered Single-family homes.